Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GTBP
DateTimeSourceHeadlineSymbolCompany
06/07/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
05/23/20247:31PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
05/23/20245:04AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GTBPGT Biopharma Inc
05/23/20245:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
05/15/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
02/14/20241:46PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
02/01/202411:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
12/21/20232:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
12/04/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
11/06/20234:25PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
11/06/20234:23PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
11/06/20234:21PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
11/01/20238:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
10/27/20234:23PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
09/19/202310:56AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
08/22/20233:55PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
08/15/20236:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
08/15/20236:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
08/07/20238:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
07/05/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
05/05/20234:30PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GTBPGT Biopharma Inc
05/05/20234:29PMEdgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:GTBPGT Biopharma Inc
05/04/20236:15PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GTBPGT Biopharma Inc
05/04/20238:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTBPGT Biopharma Inc
04/11/20236:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTBPGT Biopharma Inc
03/30/20234:02PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:GTBPGT Biopharma Inc
02/14/202311:55AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GTBPGT Biopharma Inc
01/04/20235:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTBPGT Biopharma Inc
01/04/20235:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GTBPGT Biopharma Inc
12/13/20223:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTBPGT Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:GTBP